Skip to main content

AstraZeneca aims to offset drug setback at big cancer congress

* Two lung cancer studies with AZ drugs in focus at ESMO congress
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.